Skip to content

Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing

Randomized, Double-blind Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01444703
Enrollment
236
Registered
2011-10-03
Start date
2010-10-31
Completion date
2011-06-30
Last updated
2016-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sore Throat

Keywords

Thoracic surgery, double-lumen endotracheal tube, intubation, extubation, sore throat, prevention of post-extubation sore throat

Brief summary

The investigators propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours.

Detailed description

Patients will be premedicated with up to 7.5 mg p.o. midazolam, per routine. They will be told that the study involves two different solutions for prevention of post-extubation sore throat. Patients will be randomly assigned to gargle 5 minutes before induction of general anesthesia with: 1) licorice (0.5 g); or, 2) sugar (5 g). Randomization will be based on a computer-generated table of random numbers. Licorice or sugar (placebo) will be diluted in 30 ml water and filled in a small bottle by an independent apothecary of our university. All bottles will look similar and will not be opened until just before use. Investigator and patient will be blinded to the preparation used for gargle. Patients will be asked to gargle for two minutes, but not to swallow the solution. General anesthesia will be induced with fentanyl ≈3 µg/kg, propofol ≈1.5 mg/kg, and rocuronium ≈0.6 mg/kg. Complete muscle relaxation will be confirmed by absence of palpable twitches in response to supra-maximal train-of-four stimulation of the ulnar nerve at the wrist. The trachea will then be intubated as gentle as possible. Intubation will be attempted with a Macintosh laryngoscope, but the anesthesiologists may subsequently use any other intubation equipment as necessary. Initial tube size will be 37 cm left in women and 39 cm left for men; however, other sizes can be used if clinically necessary. Endotracheal tube cuffs will be inflated with air to 20-25 mmHg as necessary to maintain an adequate seal. General anesthesia will be primarily be maintained with sevoflurane. Patients lungs will be ventilated with O2 in air, usually with an inspired oxygen fraction (FiO2) of ≈40%. However, additional oxygen will be provided as clinically necessary, especially during one-lung ventilation. End-tidal CO2 will be maintained between 32 and 35 mmHg as clinically practical. Deep of anesthesia will be monitored by using bispectral index BIS, kept between 40 and 50. Small amounts of opioid will be permitted during surgery and in preparation for extubation. At the end of surgery, an intercostal plexus block -using up to 20 ml Ropivacaine 0.1% - will be performed by the surgeons. 1000 mg paracetamol will be given intravenously ten minutes before end of surgery. Post operative pain will be treated with fractional piritramid (Dipidolor) 3 mg IV as required.

Interventions

OTHERlicorice solution

licorice (0.5 g)

sugar (5 g).

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Thoracic surgery with anticipated use of a double-lumen endotracheal tube; * Anticipated extubation in the operating room; * ASA Physical Status 1-3; * Age 18- 90

Exclusion criteria

* Tracheal pathology, including tracheostomy; * Surgery within the previous four weeks; * Upper-respiratory tract infection; * BMI higher exceeding 40 kg/m2; * Known or suspected allergy to licorice; * Use of non-steroidal anti-inflammatory drug medication within 24 hours; * Chronic opioid use; * Preoperative pain ≥ 2 on an 11-point Likert scale (0 = no pain; 10 = worst pain); * Known or suspected difficult airway.

Design outcomes

Primary

MeasureTime frameDescription
sore throat in rest after intubationup to 4 hours post-extubationWe propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours.

Secondary

MeasureTime frameDescription
post-extubation coughingup to four hours post-extubationPre-operative gargling with licorice reduces sore throat pain during the initial postoperative day. Pre-operative gargling with licorice reduces the incidence of post-extubation coughing.
amount of coughing24 hours post operativePre-operative gargling with licorice reduces the amount of coughing during the remainder of the first postoperative day.
sore throat in restfirst 24 hours after surgreyPre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours
incidence of sore throat during swallowingfirst 24 hours after surgeryPre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026